Multi-omics analysis of parthanatos related molecular subgroup and prognostic model development in stomach adenocarcinoma
PLOS One · 2025
DOI: 10.1371/journal.pone.0332988 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Xiangxin Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Abdominal Surgery, Ganzhou Cancer Hospital, Ganzhou, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project of Heilongjiang Provincial Health Commission, Health Commission of Heilongjiang Province.
Abstract (Originalsprache)
Stomach adenocarcinoma (STAD), the most prevalent histological subtype of gastric cancer, exhibits high heterogeneity and poor prognosis, posing significant therapeutic challenges. Parthanatos, a distinct form of regulated cell death mediated by poly (ADP-ribose) polymerase-1 (PARP-1), has been implicated in tumor biology and therapeutic resistance; however, the role of parthanatos-associated genes (PRGs) in STAD remains largely unexplored. In this study, we performed a comprehensive multi-omics analysis integrating transcriptomic, genomic, and clinical data from public databases to delineate the molecular landscape of PRGs in STAD. Unsupervised clustering revealed distinct PRG-related molecular subtypes with significant differences in clinical outcomes, immune infiltration profiles, and biological pathway activation. Based on machine learning algorithms, we established and validated a novel PRG-based prognostic signature, which demonstrated robust predictive performance. Moreover, single-cell RNA sequencing and in vitro functional assays were conducted to explore cellular heterogeneity and gene function. Notably, in vitro experiments, including western blot, colony formation, CCK-8, and Transwell assays, confirmed that one key PRG, COL8A1, promotes STAD cell proliferation and migration. Collectively, our findings highlight the clinical and biological significance of PRGs in STAD, offering novel biomarkers and potential therapeutic targets for STAD precision treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Abdominal Surgery, Ganzhou Cancer Hospital, Ganzhou, China.
- Department of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, China.
ORCID-Profile: Tianyi Xia
Förderung
- Project of Heilongjiang Provincial Health Commission
- Health Commission of Heilongjiang Province
Zitieren
APA
Wu, X., Cai, L., Liu, Y., Wang, B., Xia, T., & Liu, Z. (2025). Multi-omics analysis of parthanatos related molecular subgroup and prognostic model development in stomach adenocarcinoma. PLOS One. https://doi.org/10.1371/journal.pone.0332988
Vancouver
Wu X, Cai L, Liu Y, Wang B, Xia T, Liu Z. Multi-omics analysis of parthanatos related molecular subgroup and prognostic model development in stomach adenocarcinoma. PLOS One. 2025. doi:10.1371/journal.pone.0332988
BibTeX
@article{Wu2025,
author = {Wu, Xiangxin and Cai, Lianming and Liu, Yanping and Wang, Bowen and Xia, Tianyi and Liu, Zhenhua},
title = {Multi-omics analysis of parthanatos related molecular subgroup and prognostic model development in stomach adenocarcinoma},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0332988}
}
EUVIMED